FDA
approval
· 2021-01-26
FDA Approved: LAMIVUDINE — Supplemental Application (Apotex Corp.)
Summary
FDA approves a supplemental abbreviated new drug application for Lamivudine from Apotex Corp., authorizing the continued manufacture and distribution of the gen…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for LAMIVUDINE (LAMIVUDINE)